These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

736 related items for PubMed ID: 12571256

  • 1. Nephrotoxic effects in high-risk patients undergoing angiography.
    Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ, Nephrotoxicity in High-Risk Patients Study of Iso-Osmolar and Low-Osmolar Non-Ionic Contrast Media Study Investigators.
    N Engl J Med; 2003 Feb 06; 348(6):491-9. PubMed ID: 12571256
    [Abstract] [Full Text] [Related]

  • 2. Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study.
    Chuang FR, Chen TC, Wang IK, Chuang CH, Chang HW, Ting-Yu Chiou T, Cheng YF, Lee WC, Chen WC, Yang KD, Lee CH.
    Ren Fail; 2009 Feb 06; 31(3):181-8. PubMed ID: 19288321
    [Abstract] [Full Text] [Related]

  • 3. Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial.
    Juergens CP, Winter JP, Nguyen-Do P, Lo S, French JK, Hallani H, Fernandes C, Jepson N, Leung DY.
    Intern Med J; 2009 Jan 06; 39(1):25-31. PubMed ID: 18771430
    [Abstract] [Full Text] [Related]

  • 4. Iso-osmolar radio contrast iodixanol in patients with chronic kidney disease.
    Tadros GM, Malik JA, Manske CL, Kasiske BL, Dickinson SE, Herzog CA, Wilson RF, Das G, Panetta CJ.
    J Invasive Cardiol; 2005 Apr 06; 17(4):211-5. PubMed ID: 15831975
    [Abstract] [Full Text] [Related]

  • 5. Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography.
    Shin DH, Choi DJ, Youn TJ, Yoon CH, Suh JW, Kim KI, Cho YS, Cho GY, Chae IH, Kim CH.
    Am J Cardiol; 2011 Jul 15; 108(2):189-94. PubMed ID: 21545991
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of the nephrotoxic effects of iodixanol versus iohexol in patients with chronic heart failure undergoing coronary angiography or angioplasty.
    Song T, Song M, Ge Z, Li Y, Shi P, Sun M.
    J Interv Cardiol; 2017 Jun 15; 30(3):281-285. PubMed ID: 28421628
    [Abstract] [Full Text] [Related]

  • 11. Comparison of iodixanol and iohexol in renal impairment.
    Chalmers N, Jackson RW.
    Br J Radiol; 1999 Jul 15; 72(859):701-3. PubMed ID: 10624328
    [Abstract] [Full Text] [Related]

  • 12. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.
    Solomon RJ, Natarajan MK, Doucet S, Sharma SK, Staniloae CS, Katholi RE, Gelormini JL, Labinaz M, Moreyra AE, Investigators of the CARE Study.
    Circulation; 2007 Jun 26; 115(25):3189-96. PubMed ID: 17562951
    [Abstract] [Full Text] [Related]

  • 13. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function.
    Nguyen SA, Suranyi P, Ravenel JG, Randall PK, Romano PB, Strom KA, Costello P, Schoepf UJ.
    Radiology; 2008 Jul 26; 248(1):97-105. PubMed ID: 18483232
    [Abstract] [Full Text] [Related]

  • 14. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
    Jo SH, Youn TJ, Koo BK, Park JS, Kang HJ, Cho YS, Chung WY, Joo GW, Chae IH, Choi DJ, Oh BH, Lee MM, Park YB, Kim HS.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):924-30. PubMed ID: 16949481
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Iodixanol versus iopromide in patients with renal insufficiency undergoing coronary angiography with or without PCI.
    Zhang J, Jiang Y, Rui Q, Chen M, Zhang N, Yang H, Zhou Y.
    Medicine (Baltimore); 2018 May 05; 97(18):e0617. PubMed ID: 29718868
    [Abstract] [Full Text] [Related]

  • 17. Iodixanol compared to iohexol for contrast procedures: a case-matched retrospective cohort study.
    From AM, Bartholmai BJ, Williams AW, McDonald FS.
    Acta Radiol; 2008 May 05; 49(4):409-14. PubMed ID: 18415784
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study.
    Chen Y, Hu S, Liu Y, Zhao R, Wang L, Fu G, He Q, Su X, Zheng Y, Qi X, Liu H, Wang J, Gao W, Wang M, Liu S, Zheng X, He B, Yang P, Zhou S, Gao C, Qiu C.
    EuroIntervention; 2012 Nov 22; 8(7):830-8. PubMed ID: 23045301
    [Abstract] [Full Text] [Related]

  • 20. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations.
    Cheruvu B, Henning K, Mulligan J, Klippenstein D, Lawrence D, Gurtoo L, Gottlieb RH.
    J Comput Assist Tomogr; 2007 Nov 22; 31(4):493-8. PubMed ID: 17882021
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.